- Britannia Mining Solutions Inc. (BMS) will deliver assay services to global mining companies
- BMS is being funded separately from Britannia Life Sciences and is backed by a group of mining investors and advisors including Eric Sprott and Dr. Quinton Henningh
- BMS’ focus will be establishing technology-enabled assay labs which will provide faster and more accurate results, and help address the global backlog of mining assays
- Britannia Life Sciences Inc. offers an integrated suite of services to assist companies along their product development journey
- Services include product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations
- Britannia Life Sciences Inc. (BLAB) is up 12.82 per cent, trading at C$0.22 per share at 5 pm EST
Britannia Life Sciences is launching a new, independently funded and operated subsidiary to serve the global mining community.
Britannia Mining Solutions Inc. (BMS) will operate as a partially owned subsidiary of Britannia with the initial objective of setting up mining assay labs to address the global backlog in mining assays.
In establishing the business, BMS completed a non-brokered private placement for proceeds of $500,000 on March 7, 2022.
Peter Shippen, Britannia’s CEO, sat down with Shoran Devi to share the exciting news.
“Our strategy has been to disrupt the traditional analytical testing and laboratory markets across various industries through the deployment of innovative, cost and time saving technologies. Our objective in establishing BMS is to bring this strategy to the mining industry by displacing legacy processes with technologically advanced solutions.”
Britannia Life Sciences Inc. is a global platform offering an integrated suite of services to assist companies along their product development journey. Britannia’s services, which include product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations are offered to companies ranging from multinationals to start-ups, particularly in the cosmetics, food and wellness industries.
Britannia Life Sciences Inc. (BLAB) is up 12.82 per cent, trading at C$0.22 per share at 5 pm EST.